Odey Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Odey Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.49M	Sell	25,641 -2,839	-10%	-$174K	1.86%	23
2023 Q2	$1.82M	Buy	+28,480	New	+$1.91M	0.67%	26

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Odey Asset Management's BMY Position: Q3 2023 in Review

Odey Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2023, selling an estimated $174K and leaving 25,641 shares worth $1.49M. The position accounts for 1.86% of the portfolio, ranked #23.

Odey Asset Management first reported a position in BMY in Q2 2023 and has held it in 2 quarters since. The position peaked at $1.82M in Q2 2023. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Odey Asset Management held 25,641 shares of Bristol-Myers Squibb worth $1.49M as of Q3 2023.
Odey Asset Management sold 2,839 Bristol-Myers Squibb shares in Q3 2023, an estimated $174K.
Bristol-Myers Squibb made up 1.86% of Odey Asset Management's portfolio in Q3 2023, its #23 holding.
Odey Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 2 quarters since.
Odey Asset Management's Bristol-Myers Squibb position peaked at $1.82M in Q2 2023.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Odey Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.